
Izvēlieties etiķeti
redzama tieši uz flakonaLaboratorijas ziņojums
PDF- Pārbaudīts
- Dutasteride 1mg × 100 Tabs
- Laboratorija
- Analiza Białek
- Datums
- October 2026
- Rezultāts
- 1.02 mg per tablet (1 mg label)
- Pasūtījuma nr.
- Parole
Neatkarīgi pārbaudīts, ar paroli pārbaudāms tieši laboratorijā.
Dutasteride
Hair & Skin
- Laboratorijā pārbaudīts
- Sūtām no Vācijas
Pasūtījums
- DHL ar izsekošanu
- Diskrēts iepakojums
4.6 no 5 Trustpilot73 atsauksmes
Meklēts arī kā: Dutasterid
Īsumā
Dutasteride skaitļos
Galvenie rādītāji no mūsu leksikona. Velciet punktu pa līkni, lai redzētu, cik daudz paliek pēc vienas devas, pēc aprēķina.
Pilns leksikona ierakstsHow long does it stay in the body?
Share left after one dose, calculated with a half-life of ~5 weeks
Simplified model without an absorption phase, half-life from the TPD lexicon.
Half-life
about5weeks
- Class
- 5α-reductase inhibitor type 1 and type 2
- Use
- Oral1 tablet per day or every other day
- Sizes
- 1 mg1 size in the shop
What studies show
All 2 sources in the lexiconDutasteride vs finasteride in androgenetic alopecia (opens in a new tab)
Olsen et al., J Am Acad Dermatol, 2006
Zināšanas
Viss par Dutasteride
Detalizēta informācija drīzumā.
Is dutasteride approved?
Yes. In the USA it has been approved as a prescription drug for the enlarged prostate since 20 November 2001, ChEMBL lists phase 4 as the highest phase. In hereditary hair loss it is used outside this approval, there are phase 3 trials on this.
How does dutasteride differ from finasteride?
Finasteride blocks only 5-alpha reductase type 2, dutasteride both types. In a comparison trial in men with enlarged prostate blood DHT fell by 94.7 percent with the approved dose of dutasteride and by 70.8 percent with finasteride. With finasteride the values also varied much more.
What do the hair loss trials show?
The first trial with 416 men already showed more hair in a dose-dependent way, the highest dose beat finasteride. In a trial with 917 men the approved dose grew more and thicker hairs after 24 weeks than finasteride and placebo. In a Korean phase 3 trial hair count rose by 12.2 per square centimetre in 6 months, on placebo by 4.7. All trials lasted at most 6 months.
What does research show for the prostate?
In three identical trials with 4,325 men the prostate shrank by 25.7 percent in 24 months, symptoms fell by 21.4 percent and urine flow rose. The risk of acute urinary retention fell by 57 percent, of surgery by 48 percent. In the CombAT trial the combination with tamsulosin worked better on symptoms over 4 years than either drug alone.
Does dutasteride lower prostate cancer risk?
In the 4-year REDUCE trial prostate cancer was found less often on dutasteride, 22.8 percent less in relative terms. Aggressive tumours with Gleason 8 to 10, however, were more common in years 3 and 4, 12 against 1. The composite term heart failure was also more common at 0.7 against 0.4 percent.
Which side effects have been described?
In the prostate trials impotence, reduced libido, breast enlargement and ejaculation disorders occurred more often than on placebo, but rarely overall. Except for breast enlargement they became less frequent over time. A meta-analysis in hair loss found a 1.37-fold risk of sexual side effects for dutasteride, not statistically significant. In direct comparison with finasteride there was no clear difference.
Salīdzinājumi
Kā tas atšķiras
Saistītie
Saistītie produkti
Snap-8
Peptīdi · Kognīcija un miegs Kognīcija un miegs
1 izmērs
= 11.6 €/flakons
PTD-DBM
Peptīdi · Pretnovecošana Pretnovecošana
1 izmērs
= 56.8 €/flakons
Healthy Hair Skin Nails Blend
Peptīdi · Īpašie produkti un atbalsts Īpašie produkti un atbalsts
1 izmērs
par pudelīti
Finasteride
Medikamenti · Hormoni un uroloģija Hormoni un uroloģija
3 izmēri
Dutasteride
